Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)

Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)

Abstract only

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neurology 2024-04, Vol.102 (17_supplement_1)
Hauptverfasser: Okamoto, Tomoko, Sato, Wakiro, Lin, Youwei, Kimura, Yukio, Sato, Noriko, Shimizu, Yuko, Nishida, Yoichiro, Yokota, Takanori, Taketsuna, Masanori, Okada, Yu, Ishizuka, Takami, Nakamura, Harumasa, Miyake, Sachiko, Takahashi, Yuji, Yamamura, Takashi
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 17_supplement_1
container_start_page
container_title Neurology
container_volume 102
creator Okamoto, Tomoko
Sato, Wakiro
Lin, Youwei
Kimura, Yukio
Sato, Noriko
Shimizu, Yuko
Nishida, Yoichiro
Yokota, Takanori
Taketsuna, Masanori
Okada, Yu
Ishizuka, Takami
Nakamura, Harumasa
Miyake, Sachiko
Takahashi, Yuji
Yamamura, Takashi
description Abstract only
doi_str_mv 10.1212/WNL.0000000000204680
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_1212_WNL_0000000000204680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_1212_WNL_0000000000204680</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_1212_WNL_00000000002046803</originalsourceid><addsrcrecordid>eNqdj09LxDAQxYO4YHX9Bh7mqIfUJF273XPxz7Jaixb0FkJNd0fGtiQRWfDDbxbEg0fn8AZm5j3mx9iZFKlUUl2-VPep-C0lZnkhDlgir1TO80y9HrIkjgueFfPiiB17_y5EXM4XCfuuN8ZbWC6hJOyxNQSNw6hDB9WqgdIS8WDc2gbs13BL23YgHPENHss7XpVVLaEbHNQmoO2Dhy8MG3iyZEa_Nzx8UsCRLDy3ZN3g0cN5veB5Gh-4mLJJZ8jb059-wmY3103MbeOld7bTo8MP47ZaCr0n1ZFU_yXN_mnbAX9UWkY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)</title><source>Journals@Ovid Complete</source><source>Alma/SFX Local Collection</source><creator>Okamoto, Tomoko ; Sato, Wakiro ; Lin, Youwei ; Kimura, Yukio ; Sato, Noriko ; Shimizu, Yuko ; Nishida, Yoichiro ; Yokota, Takanori ; Taketsuna, Masanori ; Okada, Yu ; Ishizuka, Takami ; Nakamura, Harumasa ; Miyake, Sachiko ; Takahashi, Yuji ; Yamamura, Takashi</creator><creatorcontrib>Okamoto, Tomoko ; Sato, Wakiro ; Lin, Youwei ; Kimura, Yukio ; Sato, Noriko ; Shimizu, Yuko ; Nishida, Yoichiro ; Yokota, Takanori ; Taketsuna, Masanori ; Okada, Yu ; Ishizuka, Takami ; Nakamura, Harumasa ; Miyake, Sachiko ; Takahashi, Yuji ; Yamamura, Takashi</creatorcontrib><description>Abstract only</description><identifier>ISSN: 0028-3878</identifier><identifier>EISSN: 1526-632X</identifier><identifier>DOI: 10.1212/WNL.0000000000204680</identifier><language>eng</language><ispartof>Neurology, 2024-04, Vol.102 (17_supplement_1)</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Okamoto, Tomoko</creatorcontrib><creatorcontrib>Sato, Wakiro</creatorcontrib><creatorcontrib>Lin, Youwei</creatorcontrib><creatorcontrib>Kimura, Yukio</creatorcontrib><creatorcontrib>Sato, Noriko</creatorcontrib><creatorcontrib>Shimizu, Yuko</creatorcontrib><creatorcontrib>Nishida, Yoichiro</creatorcontrib><creatorcontrib>Yokota, Takanori</creatorcontrib><creatorcontrib>Taketsuna, Masanori</creatorcontrib><creatorcontrib>Okada, Yu</creatorcontrib><creatorcontrib>Ishizuka, Takami</creatorcontrib><creatorcontrib>Nakamura, Harumasa</creatorcontrib><creatorcontrib>Miyake, Sachiko</creatorcontrib><creatorcontrib>Takahashi, Yuji</creatorcontrib><creatorcontrib>Yamamura, Takashi</creatorcontrib><title>Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)</title><title>Neurology</title><description>Abstract only</description><issn>0028-3878</issn><issn>1526-632X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqdj09LxDAQxYO4YHX9Bh7mqIfUJF273XPxz7Jaixb0FkJNd0fGtiQRWfDDbxbEg0fn8AZm5j3mx9iZFKlUUl2-VPep-C0lZnkhDlgir1TO80y9HrIkjgueFfPiiB17_y5EXM4XCfuuN8ZbWC6hJOyxNQSNw6hDB9WqgdIS8WDc2gbs13BL23YgHPENHss7XpVVLaEbHNQmoO2Dhy8MG3iyZEa_Nzx8UsCRLDy3ZN3g0cN5veB5Gh-4mLJJZ8jb059-wmY3103MbeOld7bTo8MP47ZaCr0n1ZFU_yXN_mnbAX9UWkY</recordid><startdate>20240409</startdate><enddate>20240409</enddate><creator>Okamoto, Tomoko</creator><creator>Sato, Wakiro</creator><creator>Lin, Youwei</creator><creator>Kimura, Yukio</creator><creator>Sato, Noriko</creator><creator>Shimizu, Yuko</creator><creator>Nishida, Yoichiro</creator><creator>Yokota, Takanori</creator><creator>Taketsuna, Masanori</creator><creator>Okada, Yu</creator><creator>Ishizuka, Takami</creator><creator>Nakamura, Harumasa</creator><creator>Miyake, Sachiko</creator><creator>Takahashi, Yuji</creator><creator>Yamamura, Takashi</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20240409</creationdate><title>Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)</title><author>Okamoto, Tomoko ; Sato, Wakiro ; Lin, Youwei ; Kimura, Yukio ; Sato, Noriko ; Shimizu, Yuko ; Nishida, Yoichiro ; Yokota, Takanori ; Taketsuna, Masanori ; Okada, Yu ; Ishizuka, Takami ; Nakamura, Harumasa ; Miyake, Sachiko ; Takahashi, Yuji ; Yamamura, Takashi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_1212_WNL_00000000002046803</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Okamoto, Tomoko</creatorcontrib><creatorcontrib>Sato, Wakiro</creatorcontrib><creatorcontrib>Lin, Youwei</creatorcontrib><creatorcontrib>Kimura, Yukio</creatorcontrib><creatorcontrib>Sato, Noriko</creatorcontrib><creatorcontrib>Shimizu, Yuko</creatorcontrib><creatorcontrib>Nishida, Yoichiro</creatorcontrib><creatorcontrib>Yokota, Takanori</creatorcontrib><creatorcontrib>Taketsuna, Masanori</creatorcontrib><creatorcontrib>Okada, Yu</creatorcontrib><creatorcontrib>Ishizuka, Takami</creatorcontrib><creatorcontrib>Nakamura, Harumasa</creatorcontrib><creatorcontrib>Miyake, Sachiko</creatorcontrib><creatorcontrib>Takahashi, Yuji</creatorcontrib><creatorcontrib>Yamamura, Takashi</creatorcontrib><collection>CrossRef</collection><jtitle>Neurology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Okamoto, Tomoko</au><au>Sato, Wakiro</au><au>Lin, Youwei</au><au>Kimura, Yukio</au><au>Sato, Noriko</au><au>Shimizu, Yuko</au><au>Nishida, Yoichiro</au><au>Yokota, Takanori</au><au>Taketsuna, Masanori</au><au>Okada, Yu</au><au>Ishizuka, Takami</au><au>Nakamura, Harumasa</au><au>Miyake, Sachiko</au><au>Takahashi, Yuji</au><au>Yamamura, Takashi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)</atitle><jtitle>Neurology</jtitle><date>2024-04-09</date><risdate>2024</risdate><volume>102</volume><issue>17_supplement_1</issue><issn>0028-3878</issn><eissn>1526-632X</eissn><abstract>Abstract only</abstract><doi>10.1212/WNL.0000000000204680</doi></addata></record>
fulltext fulltext
identifier ISSN: 0028-3878
ispartof Neurology, 2024-04, Vol.102 (17_supplement_1)
issn 0028-3878
1526-632X
language eng
recordid cdi_crossref_primary_10_1212_WNL_0000000000204680
source Journals@Ovid Complete; Alma/SFX Local Collection
title Phase II Clinical Trial of NKT Cell-targeting Glycolipid OCH-NCNP1 for Patients with Relapsing Multiple Sclerosis (P9-6.015)
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T04%3A11%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Phase%20II%20Clinical%20Trial%20of%20NKT%20Cell-targeting%20Glycolipid%20OCH-NCNP1%20for%20Patients%20with%20Relapsing%20Multiple%20Sclerosis%20(P9-6.015)&rft.jtitle=Neurology&rft.au=Okamoto,%20Tomoko&rft.date=2024-04-09&rft.volume=102&rft.issue=17_supplement_1&rft.issn=0028-3878&rft.eissn=1526-632X&rft_id=info:doi/10.1212/WNL.0000000000204680&rft_dat=%3Ccrossref%3E10_1212_WNL_0000000000204680%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true